Who we are What we do Who is using our data Steering committee Operating team Trialists Former contributors Publications Data sharing Weekly update
Mapping Treatments tested Networks Research gaps
Pharmacologic treatments Nonpharmacologic treatments
Living mapping Living evidence synthesis Networks
Preventive treatments
☰

COVID-19 vaccine effectiveness

If you want to see all comparisons, please click here

Gam-COVID-Vac (Sputnik V) vs Placebo

You will find below the forest plots for this comparison with the general characteristics and risk of bias assessment for all RCTs identified.
Of note all trials may not be included in the synthesis.

Forest plots

Evidence profile

Summary of findings


Trial Type Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment		 Full description
Intervention 1 Intervention 2
NCT04530396
Gamaleya Research Institute of Epidemiology and Microbiology
Logunov D, Lancet, 2021
RESIST

Full text
Commentary
; Commentary
; Commentary
 Non replicating viral vector

GAM-COVID-VAC (SPUTNIK V)

Placebo

 RCT
Phase 3 		SARS-CoV-2- and HIV infection-free adult volunteers at 25 centers in Russia N=21977
Some concerns
Details

Full description

For risk of bias assessment, we are considering the “effect of assignment to intervention” which might not be the analysis planned and reported by investigators. Consequently, when investigators planned to assess and report the “per-protocol” effect, the risk of bias for domain 2 may be evaluated as “some concerns”. We will contact investigators to obtain the results of the intent-to-treat analysis.